contraction of the human ureter. Vesicoureteral-reflux-associated uropathy
Conditions
Interventions
Intervention 1: The control group receive normal saline. Intervention 2: The second group receive a hydroalcoholic extract of peganum harmala 1 mg / ml. Intervention 3: The third group receive a hydr
Treatment - Drugs
The control group receive normal saline.
The second group receive a hydroalcoholic extract of peganum harmala 1 mg / ml.
The third group receive a hydroalcoholic extract of peganum harmala 2 mg / ml.
Fourth group: receive hydroalcoholic extract of peganum harmala 4 mg / ml and .
Fifth group: receive pravastatinvery by low dosage
Sponsors
Vice chancellor for research of Shahrekord University of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: removed ureter samples from total nephrectomy. Exclusion criteria: Uterine tissue involved with cancer cells; Tissue infection; abnormal dilatation of the urethra
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Contraction of ureter. Timepoint: During intervention. Method of measurement: Checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Shirani
Shahrekord University of Medical Sciences
Outcome results
None listed